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Objective: The present study aims to evaluate the anticancer potential of ethanolic extract and its different fractions of Caesalpinia bonduc seeds 
against Ehrlich Ascites Carcinoma (EAC) cell lines.
Methods: Ethanolic  extract  and  its  fractions  were  subjected to  preliminary  phytochemical  screening  and  anticancer  activity  by  using in  vitro 
anticancer assay. Chemical constituents of petroleum ether fraction of C. bonduc seeds were identified by using GC-MS and the active compounds
were subjected to in silico studies.
Results: In vitro anticancer assay showed that the petroleum ether fraction of ethanolic extract of Caesalpinia bonduc seeds has potential anticancer activity.
Conclusions: Petroleum ether fraction of ethanolic extract of Caesalpinia bonduc seeds has significant anticancer activity. Further in-depth studies,
could result in the development of a good anticancer agent from the seeds of Caesalpinia bonduc.
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INTRODUCTION 
Plants play a vital role in maintaining human health and quality of 
life. Herbal treatment is based on presence of phytoconstituents 
which are responsible for treatment of diseases [1]. The focus on 
medicinal plant research has been increased worldwide because of 
the belief that “green medicine” is safe and cheaper than synthetic 
drugs [2].  
Cancer is one of the most serious threats causing death in India, 
United States and Western world. There is an anomalous number of 
plant derived anticancer drugs with diverse structural types are 
used in both clinical use and also undergoing clinical trials. This 
suggests that plants will continue to be an imperative and prized 
resource for anticancer drug discovery.  
The World Health Organization (WHO) has recently defined 
traditional medicine (including herbal drugs) as comprising 
therapeutic practices that have been in existence, often for 
thousands of years [3]. Herbal plants play a significant role not only 
in diseased conditions but also in maintaining human health and 
improving the quality of human life for thousands of years.  
More than 3000 plant species are reported to be used for cancer 
treatment. In recent years, secondary metabolites of plants 
(phytochemicals) have been extensively investigated as a source of 
medicinal agents. They have been used as a homeopathic remedy 
and have been reported for its successful treatment of certain type 
of cancers. Plant extracts have the ability of activating the apoptotic 
pathway of cancer cells and doesn’t have any ethical issues when it 
is used as drug formulations as it is purely herbal. 
Caesalpinia bonduc is a medicinal plant belonging to the family 
Caesalpiniaceae. It is popularly used in the traditional Indian system 
of medicine. It is found in India and tropical countries of the world. It 
is reported to have therapeutic properties like anti-asthmatic, anti-
diabetic, anti-inflammatory, anti-oxidant, anti-bacterial, anti-filarial, 
anti-tumor and anxiolytic activity [4 & 5]. The plant Caesalpinia 
bonduc is used to treat rheumatism, pyretic, inflammatory, 
helminthiasis, infectious diseases, estrogenic disorders, diabetes, 
fever [6], malaria, skin diseases, leprosy, paralysis and neuro 
disorders [7].  
MATERIALS AND METHODS 
Plant material 
The seeds of Caesalpinia bonduc (L.) Roxb. were procured from the 
market, Thanjavur and the seed materials were identified and 
authenticated by Dr. P. Brindha, Carism, SASTRA University, 
Thanjavur. 
Preparation of plant material 
Caesalpinia bonduc (L.) Roxb. seeds were cleaned, dried and then 
mechanically powdered.  
Extraction 
1000g of seed powder was soaked in 98% ethanol for 48 hours. The 
ethanolic extract of Caesalpinia bonduc was filtered using whatmann 
filter paper No.1. The extract was concentrated using vaccum 
evaporator. The ethanol extract was partitioned by using petroleum 
ether fraction, chloroform, ethyl acetate and ethanol successively.  
Preliminary phytochemical analysis 
Preliminary phytochemical screening was performed to identify the 
phytoconstituents. Ethanolic extract and its fractions revealed the 
presence of biologically active compounds such as phenolics, 
flavonoids, quinines, saponins, alkaloids, glycosides and tannins [8].  
In vitro anticancer studies 
Maintainence of cells 
Ehrlich Ascites Carcinoma (EAC) cell lines were maintained in 
Central Animal Facility, SASTRA University and were maintained by 
weekly intraperitonial inoculation of 1×106 cells/mouse [9]. 
Mtt assay 
EAC cell lines were cultured in 96 well plates with growth medium 
RPMI1640 and 10% FCS. Dissolved 1mg of sample (ethanol 
extract, ethyl acetate fraction and ethanol fraction) in 100 µl of 
water and 1mg of sample (petroleum ether, chloroform fractions) 
in 1% DMSO. Sample was filtered through 0.45 µm syringe filter. 
10,000cells/100 µl media were incubated with increasing 
International Journal of Pharmacy and Pharmaceutical Sciences 
ISSN- 0975-1491                 Vol 6, Issue 8, 2014 
Innovare 
Academic Sciences 
Muthuraman et al. 
Int J Pharm Pharm Sci, Vol 6, Issue 8, 311-314 
 
312 
concentrations of drug for 48 hrs at 37 ºC in CO2 incubator with 
5% CO2. After incubation, 20 µl of MTT (5mg /ml conc.) was added 
and then incubated for 3 hrs at 37°C in CO2 incubator. The Purple 
colour precipitate was formed. 10 µl of DMSO was added in all the 
wells to dissolve MTT formazon crystals and incubated for 10 min 
at 37°C in CO2 incubator. The absorbance was recorded at 590 nm 
[10]. 
% Anticancer activity = 100 - Treated sample OD x100 
Control OD 
Gc-ms analysis 
Perkin Elmer Clarus 500 GC-MS instrument was used for the analysis 
of the compounds present in fraction under study. Capillary column 
made of Elite-5ms (5% phenyl 95% dimethyl polysiloxane) was used. 
The oven program was fixed to 50ºC @ 7ºC/min to 220ºC (2 min), @ 7º 
C/min to 280ºC (10 min) and injector temperature was 280ºC.  
Helium was used as carrier gas at the flow rate of 1 ml/min. Sample 
was injected and the compounds obtained were matched using the 
library NIST 2005. 
In silico analysis 
To support the anticancer activity, the in silico approaches has been 
implemented in which the docking software autodock was used. The 
target molecule was chosen to be Bcl-2 as it is a major gene that 
codes for a large family of apoptosis regulating proteins. Compounds 
obtained from GCMS were docked with Bcl-2 and the results were 
found to be significant. 
RESULTS 
The amount of ethanol extract obtained from seed powder (1000g) 
of Caesalpinia bonduc is 37.029g. The ethanol extract was 
partitioned by using increasing polarity of solvents such as 
petroleum ether fraction (8.577g), chloroform fraction (8.676g), ethyl 
acetate fraction (0.6g) and ethanol fraction (9.811g) successively. 
Preliminary phytochemical analysis of ethanol extract and the four 
fractions of Caesalpinia bonduc seeds were shown in table 1. 
The % anticancer activity was evaluated for ethanolic seed extract 
and four fractions, which showed the anticancer property of 
Caesalpinia bonduc (Table 2 and Fig 1). 
 
Table 1: Preliminary phytochemical analysis of ethanol extract and the four fractions of seeds of Caesalpinia bonduc 
Phytoconstituent Ethanol Extract Pet-ether 
Fraction 
Chloroform Fraction Ethyl acetate Fraction Ethanol Fraction 
Phenolics - - - - + 
Flavones + - + - + 
Glycosides + - + + - 
Saponins - + - - - 
Steroids - - - - - 
Alkaloids + + + + - 
Anthraquinones - - - - - 
Quinones + - + - + 
Tannins + - + - - 
 
In vitro anticancer studies (MTT Assay) 
Table 2: % Anticancer activity of ethanolic seed extract and four fractions of Caesalpinia bonduc 





Pet ether Fraction Chloroform  
Fraction 




 1000 66.19±0.37 66.96±0.59 67.50±0.16 67.61±1.73 51.84+0.97 
 500 53.03±1.02 55.71±1.24 55.29± 0.97 55.02±0.70 39.59±0.64 
 250 50.92±2.49 52.53± 4.22 54.48± 1.67 51.30±4.54 34.00±0.75 
 125 40.05±0.54 49.20±0.16 47.82±7.84 45.87±1.19 32.74±2.21 
 62.5 37.22±1.62 46.67±2.76 38.40±0.92 44.57±1.08 31.67±3.41 
 31.25 30.82±1.24 45.33±0.97 34.31±2.70 44.22±0.92 28.15±2.32 
 15.625 29.14±3.19 43.88± 0.21 29.75±2.32 39.09±3.62 19.69±0.00 
 7.8125 17.31±4.33 38.14± 3.68 23.55±0.16 36.64±3.51 16.81±1.78 
 
 
Fig. 1: Graphical representation of MTT assay between 
Concentrations of the drug vs %anticancer activity. 
IC50 
IC50 values were obtained by plotting graph between 
concentrations of drug vs % Anticancer activity that indicated in 
table 3. Pet-ether fraction has shown the least IC50 value, which 
indicates that pet -ether fraction has highest anticancer activity 
compared to other samples. 
Table 3: IC50 values for ethanol extract and its four fractions of 
Caesalpinia bonduc seeds 
 Sample  IC50 µg/ml 
Pet- ether Fraction  120 
Chloroform Fraction  140 
Ethyl acetate Fraction  190 
Ethanol Fraction  220 
Ethanol Extract  900 
 
Gc-ms results 
From IC 50 values, petroleum ether fraction was found to have 
higher anticancer property and hence it was subjected to GCMS, in 
order to understand the compounds present in the fraction. GC-MS 
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profile of Petroleum ether fraction of Caesalpinia bonduc seeds was 
shown in Fig 2.  
 
Fig 2: GC-MS profile of Petroleum ether fraction of Caesalpinia 
bonduc seeds chromatogram (x-axis = Retention time, y-axis = 
% intensity/%abundance) 
In silico analysis 
The cyclic compounds obtained from the GCMS analysis of 
petroleum ether fraction of seed extract of caesalpinia bonduc were 
n-Butyric acid tetrahydrofurfuryl ester, Cis11-Hexadecenal, 1H-
Naphtho[2,1-b] pyran,3-ethenyl dodecahydro-3,4a,7,7,10a-penta 
methyl. In order to understand the anticancer potential of the 
compounds present in the fraction, these compounds were docked 
with Bcl-2 anti-apoptosis protein which showed the binding energy 
of each of the compounds. It was understood that 1H-Naphtho[2,1-
b]pyran,3-ethenyldodecahydro-3,4a,7,7,10a-pentamethyl with least 
binding energy (-6.42 kcal/mol) was considered the best protein-
ligand complex fit. This was because of the lowest amount of energy 
needed by 1H-Naphtho[2,1-b]pyran,3-ethenyldodecahydro-3,4a,7,7, 
10a-pentamethyl-, [3R-(3à,4aá,6aà,10aá,10bà)]- to bind with the 
Bcl-2 protein receptor and cause anti-apoptosis thereby successfully 
killing EAC cell lines. The energies of these compounds with Bcl-2 
protein were tabulated in table 4. Pictorial representations of 
docking of compounds with Bcl2 were shown in Fig 3, 4 and 5. 
 
Table 4: Docking of compounds in the pet ether fraction of seed extract of Caesalpinia bonduc with Bcl2 
Ligand Binding Energy(kcal/mol) 







Fig. 3: Pictorial representation of of docking of n-
Butyric acid tetrahydrofurfuryl Hexadecenal with 
ester with Bcl-2. 
 
Fig. 4: Pictorial representation docking of 
Cis11- Hexadecenal with Bcl-2. 
 




(3à,4aá,6aà,10aá,10bà) with Bcl-2. 
 
DISCUSSION 
The test for in vitro anticancer (MTT assay) revealed the antitumor 
potential of seed extract of Caesalpinia bonduc. The % anticancer 
activity was increasing with increase in concentration of seed 
extract. The petroleum ether fraction, the concentration was ranging 
from 7.8125 to 1000µg/ml shows the significant % of cytotoxicity 
was obtained were 38.1412 % and 66.96%. This indicates the higher 
therapeutic values of the Petroleum ether fraction showed the least 
IC50 value compared to other samples. 
The phytochemical analysis of ethanolic extract and the fractions of 
Caesalpinia bonduc seeds showed the presence of phenols, flavones, 
alkaloids, glycosides, quinones, saponins and tannins. The pet ether 
fraction of Caesalpinia bonduc, when subjected to GCMS analysis (Fig 
2) showed the presence of various phytochemical compounds from 
which 3 cyclic compounds were identified. They were docked into 
the anti-apoptotic protein Bcl-2. Docking shows the binding energy 
of each of the compounds with Bcl-2 protein. It was understood that 
1H-Naphtho[2,1-b]pyran,3-ethenyl dodecahydro-3,4a,7,7,10a-penta 
methyl with least binding energy (-6.42 kcal/mol) was considered 
the best protein-ligand complex fit. This was because of the lowest 
amount of energy needed by 1H-Naphtho[2,1-b]pyran,3-
ethenyldodecahydro-3,4a,7,7,10a-pentamethyl to bind with the Bcl-
2 protein receptor and cause anti-apoptosis thereby successfully 
killing EAC cell lines. Hence from the current study it is evident, that 
the pet ether fraction of Caesalpinia bonduc seeds can be developed 
as a potent anticancer drug. 
CONCLUSION  
In vitro anticancer assay showed that the petroleum ether fraction of 
ethanolic extract of Caesalpinia bonduc seeds has potential 
anticancer activity. It has shown high potency in killing EAC cell lines 
through induced apoptosis. Hence, this work could be the silver 
lining in further researches in anticancer herbal therapy against 
other breast cancer cell lines.  
Further, in silico approaches also indicate that the compound 1H-
Naphtho[2,1-b]pyran,3-ethenyldodecahydro-3,4a,7,7,10a-
pentamethyl from pet ether fraction showed the least binding 
energy for protein-ligand interaction, which can be obtained and 
purified in the future as a potent drug against EAC cell lines. 
This work has confirmed that herbal remedies are effective in 
treating cancer. It was concluded that seed extract of Caesalpinia 
bonduc was effective against EAC cell lines and can be developed as a 
drug for treating Ehrlich ascites carcinoma cell lines in the near 
future. 
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